Peak ranked 35th in "China's top 50 cement"
Release time:
2020-08-14
Peak Ranked 35 in "China Cement 50 Top"
, up 6 from the previous year's ranking
News 4 11 , the "2018 China Cement 50 Top High-level Forum and China Cement Association Council Conference" with the theme of "Promoting the Optimization of Production Capacity and Increasing Benefits to a New Era of High-quality Development in the Industry" was held in Chengdu. Jianfeng Group was invited to participate and was awarded the medal of "China Cement 50 ", ranking 35 .
2018 is the first year to implement the spirit of the 19th National Congress of the Communist Party of China. It is the 32nd anniversary of the reform and opening up. It is a decisive victory in building a well-off society in an all-round way, implementing the 13th Five-Year Plan, and connecting the preceding and the following. The key year. The China Cement Association and the Sichuan Cement Association jointly organized this conference. The purpose is to thoroughly study and implement the spirit of the 19th National Congress of the Communist Party of China, guided by Xi Jinping's thoughts on socialism with Chinese characteristics in the new era, practice the new development concept, and adhere to cement stability. The general tone, deepen the supply-side structural reforms, accelerate the transformation of the cement industry from high-speed growth to high-quality development, and improve industry efficiency.
50 enterprises in the national cement clinker production capacity in 2018 . It is understood that this ranking is determined by the China Cement Association based on the production capacity database and after verification with the data of the cement (building materials) associations of various provinces, municipalities and autonomous regions. By the end of 2017 , the cement clinker design capacity of the top 50 large enterprise groups in China (excluding Hong Kong, Macao and Taiwan) totaled 13.68 .5 billion tons, accounting for 75% of the country's total capacity . Jianfeng Group ranked 35 with an annual clinker production capacity of 601 tons. In addition, according to the ranking of the top 50 enterprises in national cement clinker production capacity released by China Cement Association 2017 at the beginning of the year, Jianfeng Group ranked 41 . After a year, it has raised 6 positions.
50 strong enterprises, provincial (municipal, autonomous region) cement associations and representatives of government authorities attended the industry event. The 19th China International Cement Technology and Equipment Exhibition was also held during the conference. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page